bpc-157 fda warning september 2025 Heal or Harm: Body Protective Compound-157 in the Gray Zone The U.S. Food and Drug

Higher exposure and a smaller fat reserve suggest greater side-effect and lean-mass risk, but no long-term trial has measured the outcome

It's like, who knows what that is

It also mitigates the adverse effects of nonsteroidal anti-inflammatory drugs and alcohol on the gastric epithelium

DSIP Research# DSIP has a larger but lower-quality evidence base that includes human data: Schneider-Helmert (1987) -- reported acute sleep-inducing effects of IV DSIP in normal subjects, with sleep increased 59% within a 130-minute observation window Schneider-Helmert & Schoenenberger (1992) -- double-blind study in chronic insomniacs showing improved sleep efficiency

Additional research discussions may reference BPC-157 10MG in the context of nitric-oxide signaling, endothelial protection pathways, oxidative-stress panels, and neuroprotection readouts in injury-model systems

De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE, et al